Evidence That Baseline Levels of Low-Density Lipoproteins Cholesterol Affect the Clinical Response of Graves ’ Ophthalmopathy to Parenteral Corticosteroids

DiscussionWe found that, in patients with active GO, both an early clinical response to ivGC therapy and baseline LDLc levels are significant determinants of GO outcome (W12CAS). These data support the need of a cholesterol-lowering treatment before addressing these patients to ivGC therapy.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research